Aortic Valve
A 32-year-old man presented with shortness of breath, exertional fatigue, and chest pain. He underwent a Ross procedure in early childhood for rheumatic aortic valve disease, during which a 22 mm homograft was used in...
This 20-year propensity-matched study, utilizing data from the UK National Adult Cardiac Surgery Audit, examined whether mitral valve repair (MVr) offers better early outcomes than replacement (MVR) in patients with...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Bart P. van Putte, a cardiothoracic surgeon at the St. Antonius Hospital in Nieuwegein, Netherlands, and the Amsterdam University...
The video begins with an interview featuring CTSNet Senior Editor—Education Vincent Gaudiani, a Clinical Associate Professor of Cardiothoracic Surgery at Stanford University in Stanford, California, USA, and Lorena Montes, a...
The authors present a video describing the surgical management of a 38-year-old female patient with a 5.1 cm ascending aortic aneurysm, aortic root dilation, and paroxysmal atrial fibrillation that required...
This article examines the results of the COMMENCE trial, which evaluated the safety and effectiveness of surgical aortic valve replacement using RESILIA tissue valves during a five-year period in patients...
Development of myocardial fibrosis in patients with aortic stenosis precedes left ventricular decompensation and is associated with an adverse long-term prognosis. This study aimed to investigate whether early valve intervention...
Neurohormonal modulation and afterload reduction are essential for treating heart failure with reduced ejection fraction (HFrEF). In HFrEF patients with concomitant moderate aortic stenosis (AS), therapy with transcatheter aortic valve...
This study compared outcomes between patients undergoing valve-in-valve transcatheter aortic valve replacement (ViV TAVR) and redo surgical aortic valve replacement (redo SAVR) using a retrospective analysis of institutional databases, which...
The EARLY TAVR trial investigators randomly assigned patients with asymptomatic severe aortic stenosis to undergo either early transfemoral transcatheter aortic valve replacement (TAVR) or clinical surveillance. The primary end point...
Aortic stenosis is the most prevalent valvular heart condition necessitating surgical intervention, with full sternotomy (FS) traditionally being the standard approach for surgical aortic valve replacement (SAVR). However, many patients...
The role of transcatheter aortic valve replacement (TAVR) for the treatment of aortic stenosis in the pre- and post-lung transplant population is limited. This specific patient population is considered high...
This study reports on the seven-year outcomes of an international trial, which evaluated a novel bioprosthetic aortic valve prosthesis aimed at improving tissue durability. The trial was conducted between January...




